Solmedix

About Solmedix

Solmedix, founded in Seoul, South Korea in 2015, operates as a service provider for medical device development and commercialization. The company's core business revolves around its 'MOSAIC Platform,' an open innovation business platform designed to evaluate and commercialize ideas in the medical field. This platform reduces development costs and increases the likelihood of success by assessing the feasibility of ideas across clinical, market, technological, intellectual property, and insurance sectors before development begins.

Solmedix provides a comprehensive suite of services that includes the diagnosis of medical device ideas, prototype production and development, patent assistance, and support for preclinical and empirical research. The company's process utilizes an 'Expert Blind Evaluation' (EBE) through its 'be-Solution' program to ensure objectivity in assessing business feasibility. This collaborative model involves joint development with the organization to which the idea proposer belongs. Solmedix serves startups and other entities with medical device concepts, guiding them from the idea stage to product launch and technology transfer.

The company has raised $5.95M in funding from investors including Hugel, K-Bio HealthCare, and Seoul Business Agency. Solmedix holds a license for the manufacturing of medical devices, obtained in March 2017. The company also has pending patents for a portable light-guided injection device.